Anke Renger - Concepedia

Author

Anke Renger

Max Delbrück Center

Also Known As

A RENGER, A Renger, A. Renger, Anke Renger, Renger, Anke

Publications

354

Citations

H-Index

Concepts

All Affiliations

Max Delbrück Center Charité - Universitätsmedizin Berlin University of Göttingen University Medical Center Utrecht German Centre for Cardiovascular Research

About

Anke Renger is an author at Max Delbrück Center specializing in medicine, cell signaling, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	169
2	Cell Biology	3	3	155
3	Public Health	1	1	14
4	Cellular Physiology	1	1	15
5	Nephrology	1	1	14

Anke Renger

Publications

348

Citations

H-Index

Page 1

	Year	Citations
β-Catenin downregulation attenuates ischemic cardiac remodeling through enhanced resident precursor cell differentiation Laura C. Zelarayán, Claudia Noack, Belaïd Sekkali, Proceedings of the National Academy of Sciences Cardiac MuscleCardiomyopathyDevelopmental BiologyCell RegulationMedicine	2008	128
NF- B activation is required for adaptive cardiac hypertrophy Laura C. Zelarayán, Anke Renger, Claudia Noack, Cardiovascular Research	2009	81
Preclinical evidence for the therapeutic value of TBX5 normalization in arrhythmia control Franziska S Rathjens, Alica Blenkle, Lavanya M Iyer, Cardiovascular Research	2020	61
<i>Krueppel</i> ‐like factor 15 regulates Wnt/β‐catenin transcription and controls cardiac progenitor cell fate in the postnatal heart Claudia Noack, Maria‐Patapia Zafiriou, H. J. Schaeffer, EMBO Molecular Medicine	2012	37
The Four and a Half LIM-Domain 2 Controls Early Cardiac Cell Commitment and Expansion Via Regulating β-Catenin-Dependent Transcription Anke Renger, Maria‐Patapia Zafiriou, Claudia Noack, Stem Cells Cardiac MuscleCardiac Progenitor CellsCardiac RegenerationStem Cell BiologyCell Specialization	2013	15
Echocardiographic evaluation of left ventricular dimensions and function in chronic hemodialysis patients with cardiomegaly. Anke Renger, Marion Müller, Jutzler Ga, PubMed Heart FailureDialysis TherapyHemodialysis PatientsStructural Heart DiseaseDiastolic Function	1984	14
Hepoxilin A3 protects β-cells from apoptosis in contrast to its precursor, 12-hydroperoxyeicosatetraenoic acid Maria‐Patapia Zafiriou, Laura C. Zelarayán, Claudia Noack, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids InflammationHepoxilin A3MedicineLipid PeroxidationApoptosis	2011	12

Page 1